Curaleaf Holdings Inc (CURA)

Currency in CAD
3.36
-0.09(-2.61%)
Closed·
CURA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.343.52
52 wk Range
0.996.98
Key Statistics
Bid/Ask
3.35 / 3.43
Prev. Close
3.45
Open
3.46
Day's Range
3.34-3.52
52 wk Range
0.99-6.98
Volume
519.33K
Average Volume (3m)
1.02M
1-Year Change
57.7465%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CURA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
4.94
Upside
+47.03%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

Curaleaf Holdings Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Curaleaf Company Profile

Curaleaf Holdings, Inc. produces and distributes cannabis products in the United States and internationally. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of hemp-derived THC products through wholesale channels. The company is headquartered in Stamford, Connecticut.

Employees
5519
Market
Canada

Compare CURA to Peers and Sector

Metrics to compare
CURA
Peers
Sector
Relationship
P/E Ratio
−6.9x−2.4x−0.6x
PEG Ratio
0.19−0.020.00
Price/Book
2.3x0.7x2.6x
Price / LTM Sales
1.5x1.2x3.4x
Upside (Analyst Target)
45.0%68.3%42.0%
Fair Value Upside
Unlock33.4%5.8%Unlock

Analyst Ratings

7 Buy
1 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 4.94
(+47.03% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Canaccord Genuity
Buy5.00+48.81%-Maintain31/10/2025
Roth/MKM
Buy4.00+19.05%5.00Maintain04/03/2025
Canaccord Genuity
Buy6.00+78.57%7.25Maintain25/02/2025

Earnings

Latest Release
Nov 05, 2025
EPS / Forecast
-0.0656 / -0.0725
Revenue / Forecast
320.24M / 317.11M
EPS Revisions
Last 90 days

People Also Watch

54.07
PPL
+0.91%
99.08
MRU
+1.15%
3.75
BITF
+0.81%

FAQ

What Is the Curaleaf (CURA) Share Price Today?

The live Curaleaf share price today is 3.36

What Stock Exchange Does Curaleaf (CURA) Trade On?

Curaleaf is listed and trades on the Toronto Stock Exchange.

What Is the Ticker (Stock Symbol) for Curaleaf?

The stock symbol (also called a 'ticker') for Curaleaf is "CURA."

What Is the Current Curaleaf Market Cap?

As of today, Curaleaf market capitalisation is 2.60B.

What Is Curaleaf's (CURA) Earnings Per Share (TTM)?

The Curaleaf EPS is currently -0.37 (Trailing Twelve Months).

When Is the Next Curaleaf Earnings Date?

Curaleaf's next earnings report will be released on 10 Mar 2026.

Is CURA a Buy or Sell From a Technical Analyst Perspective?

Based on today's Curaleaf moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Curaleaf Stock Split?

Curaleaf has split 2 times. (See the CURA stock split history page for full effective split date and price information.)

How Many Employees Does Curaleaf Have?

Curaleaf has 5519 employees.

What is the current trading status of Curaleaf (CURA)?

As of 21 Jan 2026, Curaleaf (CURA) is trading at a price of 3.36, with a previous close of 3.45. The stock has fluctuated within a day range of 3.34 to 3.52, while its 52-week range spans from 0.99 to 6.98.

What Is Curaleaf (CURA) Price Target According to Analysts?

The average 12-month price target for Curaleaf is CAD4.94, with a high estimate of CAD6.02517986 and a low estimate of CAD4.38848921. 7 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +47.03% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.